Healthcare -
Biotechnology - NASDAQ - US
$ 1.73
-4.55 %
$ 123 M
Market Cap
-0.99
P/E
CCCC - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities CCCC - C4 Therapeutics, Inc.
45.3 M
LAST VALUE
528.69%
2 YEAR CAGR
184.32%
5 YEAR CAGR
0.00%
10 YEAR CAGR